Physician

Robert G Brousse, M.D.

According to 2025 Medicare claims, Robert Brousse, M.D. (NPI: 1699873141) practices otolaryngology in the New Orleans-Metairie, LA market, with the plurality of this provider's patient population coming from Jefferson, LA. This provider's primary affiliated billing organization is MEDICAL PLAZA ENT PHYSICIANS A PROFESSIONAL MEDICAL CORP (NPI: 1124283163; TIN: 721258141) and primary practice location at 70006-3001.

Brousse's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 881 traditional Medicare patients, billed 25,510 HCPCS/CPT codes, and received $165,203 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 6,094 prescription claims across 1,918 beneficiaries totaling $93,210 in drug costs, led by Fluticasone Propionate (Fluticasone Propionate). DME data shows 180 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $146,166 to $93,210. In contrast, DME billing represents a smaller volume and rose steadily, from $4,862 to $6,995.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,003	6,096	$171,924
2016	1,067	6,507	$183,675
2017	1,110	8,712	$226,524
2018	1,074	8,858	$227,644
2019	1,070	8,254	$223,001
2020	816	5,865	$165,730
2021	815	6,238	$201,205
2022	945	6,924	$232,813
2023	933	7,330	$223,861
2024	881	25,510	$165,203

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,346	4,866	$146,166
2016	1,446	5,017	$143,561
2017	1,461	4,974	$115,870
2018	1,424	4,784	$112,462
2019	1,464	4,634	$99,117
2020	1,219	4,181	$92,793
2021	1,380	4,641	$90,406
2022	1,635	5,356	$106,918
2023	1,804	5,664	$104,838
2024	1,918	6,094	$93,210

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	106	$2,354
2016	N/R	69	$1,179
2017	25	173	$3,876
2018	29	183	$4,269
2019	13	141	$4,143
2020	26	151	$3,346
2021	38	179	$5,750
2022	55	193	$4,201
2023	11	177	$4,428
2024	26	180	$5,606

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	718	1,301	$56
69210	Removal of impacted ear wax	340	411	$30
96372	Injection of drug or substance under skin or into muscle	414	1,217	$9
J2010	Injection, lincomycin hcl, up to 300 mg	446	702	$7
J1010	Injection, methylprednisolone acetate, 1 mg	359	19,480	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluticasone Propionate	Fluticasone Propionate	1,007	55,855	$14,884
Ipratropium Bromide	Ipratropium Bromide	508	20,666	$13,426
Cefuroxime	Cefuroxime Axetil	639	6,371	$6,797
Cefdinir	Cefdinir	382	3,773	$6,465
Epinephrine	Epinephrine	19	241	$4,531

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	N/R	18	$1,485
A7030	Full face mask used with positive airway pressure device, each	N	N/R	18	$1,424
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	27	$732
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	14	$634
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	13	$383

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Hikma Pharmaceuticals USA
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert G. Brousse, M.D.?

Tedicare shows public-source Medicare data for Robert G. Brousse, M.D. (NPI 1699873141), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert G. Brousse, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert G. Brousse, M.D.?

Robert G. Brousse, M.D. is linked to MEDICAL PLAZA ENT PHYSICIANS A PROFESSIONAL MEDICAL CORP (billing NPI 1124283163) in the available physician profile data.

Does Robert G. Brousse, M.D. have Open Payments data?

Robert G. Brousse, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.